Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations
- 3 January 2008
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 48 (3) , 391-398
- https://doi.org/10.1016/j.jhep.2007.09.020
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsGastroenterology, 2006
- Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127Hepatology, 2006
- Evolution of multi-drug resistant hepatitis B virus during sequential therapyHepatology, 2006
- Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B VirusAntimicrobial Agents and Chemotherapy, 2006
- Variant of Hepatitis B Virus with Primary Resistance to AdefovirNew England Journal of Medicine, 2006
- Virologic response and resistance to adefovir in patients with chronic hepatitis BJournal of Hepatology, 2005
- Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti‐hepatitis B e‐positive chronic hepatitisAlimentary Pharmacology & Therapeutics, 2005
- Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensationJournal of Hepatology, 2005
- Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir†Hepatology, 2005
- Week 48 Resistance Surveillance in Two Phase 3 Clinical Studies of Adefovir Dipivoxil for Chronic Hepatitis BHepatology, 2003